Alberto J. Espay, MD, MSc, comments on the tension between viewing Parkinson's disease as unique to each patient and the prospect of universal treatments.
The FDA has just approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa).
Although brain-implanted electrodes do help minimize the effects of Parkinson's disease and other neurological disorders, ...
The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...
The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...
Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.
A high dose of the investigational gene therapy AAV-GAD, which delivers the glutamic acid decarboxylase ( GAD) gene to the ...
Parkinson's disease has been getting increased attention in the media, but misinformation abounds. Here, a Parkinson's expert ...
Parkinson's disease: early signs and symptoms to look out for after John Stapleton reveals diagnosis
BBC presenter John Stapleton has revealed he has been diagnosed with Parkinson’s disease. The 78-year-old who is best known ...
Medpage Today on MSN5d
Continuous Parkinson's Disease Therapy Wins FDA Nod"For too long, the Parkinson's community has had limited treatment options for advanced disease," Robert Hauser, MD, MBA, of ...
She was diagnosed with Parkinson’s disease two years ago. She started having tremors probably two years before her diagnosis, but they were being attributed to longtime use of a psychiatric medication ...
Over-reliance on symptom scales complicates the interpretation of research results for patients and clinicians. For future ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback